Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polymorphic repeat in AIB1 does not alter breast cancer risk.

C A Haiman1, S E Hankinson, D Spiegelman

  • 1Channing Laboratory, Department of Medicine, Harvard School of Public Health, 191 Longwood Avenue, Boston, MA 02115, USA. nhchr@channing.harvard.edu

Breast Cancer Research : BCR
|November 1, 2000
PubMed
Summary

This study found no link between the AIB1 gene polymorphism and breast cancer risk in postmenopausal Caucasian women. The AIB1 genotype does not appear to affect breast cancer incidence or tumor characteristics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trajectories of femorotibial cartilage thickness among persons with or at risk of knee osteoarthritis: development of a prediction model to identify progressors.

Osteoarthritis and cartilage·2018
Same author

Poor replicability of recommended exercise interventions for knee osteoarthritis: a descriptive analysis of evidence informing current guidelines and recommendations.

Osteoarthritis and cartilage·2018
Same author

Diagnostic performance of knee physical exam and participant-reported symptoms for MRI-detected effusion-synovitis among participants with early or late stage knee osteoarthritis: data from the Osteoarthritis Initiative.

Osteoarthritis and cartilage·2018
Same author

Capacity for evidence-informed policymaking across Europe: development and piloting of a multistakeholder survey.

Public health·2018
Same author

Mitochondrial DNA haplogroups associated with MRI-detected structural damage in early knee osteoarthritis.

Osteoarthritis and cartilage·2018
Same author

Signal intensity alteration within infrapatellar fat pad predicts knee replacement within 5 years: data from the Osteoarthritis Initiative.

Osteoarthritis and cartilage·2018

Area of Science:

  • Genetics
  • Oncology
  • Epidemiology

Background:

  • The AIB1 gene plays a role in hormone signaling pathways relevant to breast cancer.
  • Polymorphisms in AIB1, such as glutamine repeat variations, are investigated for their potential impact on cancer risk.
  • Understanding genetic predispositions is crucial for breast cancer prevention and personalized medicine.

Purpose of the Study:

  • To investigate the association between a specific glutamine repeat polymorphism in the AIB1 gene and the risk of developing breast cancer.
  • To determine if AIB1 genotype influences specific tumor characteristics in breast cancer patients.
  • To evaluate the role of AIB1 genetic variations in postmenopausal breast cancer risk within a Caucasian population.

Main Methods:

  • A case-control study design was employed, nested within the Nurses' Health Study cohort.

Related Experiment Videos

  • The study included 464 breast cancer cases and 624 control participants.
  • Genotyping for the AIB1 glutamine repeat polymorphism was performed to assess genetic variations.

    • Main Results:

    • No statistically significant association was found between the AIB1 genotype and overall breast cancer incidence.
    • The AIB1 polymorphism did not correlate with specific tumor characteristics, such as hormone receptor status or grade.
    • These results indicate a lack of influence of the AIB1 repeat genotype on breast cancer risk in the studied population.

    Conclusions:

    • The AIB1 glutamine repeat genotype is not associated with an increased risk of postmenopausal breast cancer in Caucasian women.
    • Genetic variations in AIB1 do not appear to be a significant factor in breast cancer development or progression in this cohort.
    • Further research may explore other genetic or environmental factors contributing to breast cancer risk.